Stock KROS KEROS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Keros Therapeutics, Inc.

Equities

KROS

US4923271013

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-30 pm EDT 		5-day change 1st Jan Change
56.39 USD -3.80% Intraday chart for Keros Therapeutics, Inc. +2.17% +41.83%
Mar. 19 Morphic Holding Names Simon Cooper as Chief Medical Officer MT
Mar. 15 Keros Therapeutics Shares Rise After FDA Fast Track Designation for Potential Anemia Drug MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. KROS Stock
  4. Revisions Keros Therapeutics, Inc.